Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy

Despite major advances in cancer treatment, pancreatic cancer is still incurable and the treatment outcomes are limited. The aggressive and therapy-resistant nature of pancreatic cancer warrants the need for novel treatment options for pancreatic cancer management. Drug repurposing is emerging as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramachandran, Sharavan, Srivastava, Sanjay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527685/
https://www.ncbi.nlm.nih.gov/pubmed/33024816
http://dx.doi.org/10.1016/j.omto.2020.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527685/
https://www.ncbi.nlm.nih.gov/pubmed/33024816
http://dx.doi.org/10.1016/j.omto.2020.08.019

Ejemplares similares